Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.
J Cardiovasc Electrophysiol. 2011 May;22(5):605-12. doi: 10.1111/j.1540-8167.2010.01920.x. Epub 2010 Oct 11.
The aim of this review is to summarize the available evidence on gender-related differences in outcome of invasive electrophysiological procedures. Gender exerts significant influences on the epidemiology, pathophysiology, and clinical presentation of many cardiac rhythm disorders. Women with supraventricular arrhythmias have a higher incidence of atrioventricular nodal reentrant tachycardia, a lower prevalence of atrioventricular accessory pathways, and increased arrhythmia inducibility during luteal phases of the menstrual cycle. Catheter ablation of supraventricular arrhythmias appears equally effective in the 2 genders, although women present to catheter ablation later, with more symptoms, and after having failed more antiarrhythmic drugs. The outcome of catheter ablation of atrial fibrillation in women has been reported worse than in men, which may be explained by a later referral. Accordingly, women present to catheter ablation with a higher incidence of long-standing persistent atrial fibrillation. Of note, the outcome of catheter ablation of atrial flutter does not seem to differ between genders. To date, with regard to ventricular arrhythmias, no gender-related differences in outcome of catheter ablation procedures have been reported. However, pathophysiology and risk factors underlying ventricular arrhythmias appear different in the two genders. Severe left ventricular dysfunction does not perform equally as a predictor for sudden cardiac death in women as compared to men, and the survival benefit of prophylactic implantable cardioverter-defibrillator (ICD) implantation in women is inconclusive. On the other hand, the clinical outcome after cardiac resynchronization therapy seems to be more favorable in women, who experience a greater degree of reverse left ventricular remodeling.
本综述旨在总结关于性别与介入性电生理程序结果之间差异的现有证据。性别对许多心律失常的流行病学、病理生理学和临床表现有显著影响。女性的室上性心律失常发生率较高,房室结折返性心动过速发生率较高,房室旁路的发生率较低,在黄体期月经周期中心律失常的诱发性增加。导管消融治疗室上性心律失常在两性中的效果相当,但女性接受导管消融的时间较晚,症状更多,抗心律失常药物治疗失败的次数也更多。女性的导管消融治疗房颤的结果比男性差,这可能是由于转诊较晚所致。因此,女性接受导管消融治疗的房颤多为持续性房颤。值得注意的是,导管消融治疗房扑的效果在两性之间似乎没有差异。迄今为止,就室性心律失常而言,导管消融术的结果没有性别差异的报道。然而,室性心律失常的病理生理学和危险因素在两性中似乎有所不同。严重的左心室功能障碍不能像男性一样作为女性心源性猝死的预测因子,预防性植入式心脏复律除颤器(ICD)植入的生存获益尚无定论。另一方面,女性接受心脏再同步治疗后的临床结果似乎更有利,她们经历了更大程度的左心室逆向重构。